記住我
Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: Preventing disease and death worldwide. ESC Heart Fail. 2014; 1(1): 4–25. DOI: https://doi.org/10.1002/ehf2.12005
Badan Penelitian dan Pengembangan Kesehatan Republik Indonesia. Riset kesehatan dasar 2013. Jakarta; Kementerian Kesehatan Republik Indonesia; 2013.
Pokja Gagal Jantung Pengurus Pusat Perhimpunan Dokter Kardiovaskular Indonesia 2018. Data registri nasional. Jakarta: Pokja Gagal Jantung Pengurus Pusat Perhimpunan Dokter Kardiovaskular Indonesia 2018; 2019. http://inahfcarmet.org/halaman/detail/national-hf-awareness-day (accessed February 10, 2021).
Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: Findings from the EVEREST trial. Eur Heart J. 2013; 34(11): 835–843. DOI: https://doi.org/10.1093/eurheartj/ehs444
Recommended methods for measurement of red-cell and plasma volume: International Committee for Standardization in Haematology. J Nucl Med. 1980; 21(8): 793–800.
Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. Jama. 2005; 294(13): 1625–1633. DOI: https://doi.org/10.1001/jama.294.13.1625
Ling HZ, Flint J, Damgaard M, Bonfils PK, Cheng AS, Aggarwal S, et al. Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail. 2015; 17(1): 35–43. DOI: https://doi.org/10.1002/ejhf.193
Yoshihisa A, Abe S, Sato Y, Watanabe S, Yokokawa T, Miura S, et al. Plasma volume status predicts prognosis in patients with acute heart failure syndromes. European Heart Journal Acute Cardiovascular Care. 2018; 7(4): 330–338. DOI: https://doi.org/10.1177/2048872617690889
Shirakabe A, Asai K, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, et al. Prognostic value of both plasma volume status and nutritional status in patients with severely decompensated acute heart failure. CJC Open. 2019; 1(6): 305–315. DOI: https://doi.org/10.1016/j.cjco.2019.10.001
Tamaki S, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, et al. Prognostic value of calculated plasma volume status in patients admitted for acute decompensated heart failure―A prospective comparative study with other indices of plasma volume. Circulation Reports. 2019; 1(9): 361–371. DOI: https://doi.org/10.1253/circrep.CR-19-0039
Chouihed T, Rossignol P, Bassand A, Duarte K, Kobayashi M, Jaeger D, et al. Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: Results from the PARADISE cohort. Clin Res Cardiol. 2019; 108(5): 563–573. DOI: https://doi.org/10.1007/s00392-018-1388-y
Harjola VP, Mebazaa A, Čelutkienė J, Bettex D, Bueno H, Chioncel O, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 2016; 18(3): 226–241. DOI: https://doi.org/10.1002/ejhf.478
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2021; 42(36): 3599–3726. DOI: https://doi.org/10.1093/eurheartj/ehab368
Ismail N, Neyra R, Hakim R. Plasmapheresis. In: Handbook of dialysis. 2007; 3: 231–262.
Longo D. Table 220-15: Body fluids and other mass data. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J (eds.), Harrison’s principles of internal medicine. 18th ed. 2011. p. 1450.
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37(1): 67–119. DOI: https://doi.org/10.1093/eurheartj/ehv317
Sîrbu O, Floria M, Dascalita P, Stoica A, Adascalitei P, Sorodoc V, et al. Anemia in heart failure—From guidelines to controversies and challenges. Anatol J Cardiol. 2018; 20(1): 52–59. DOI: https://doi.org/10.14744/AnatolJCardiol.2018.08634
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145(4): 247–254. DOI: https://doi.org/10.7326/0003-4819-145-4-200608150-00004
Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, et al. Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension. Eur Respir J. 2011; 38(2): 359–367. DOI: https://doi.org/10.1183/09031936.00148310
Dupont M, Mullens W, Tang WH. Impact of systemic venous congestion in heart failure. Curr Heart Fail Rep. 2011; 8(4): 233–241. DOI: https://doi.org/10.1007/s11897-011-0071-7
James KB, Stelmach K, Armstrong R, Young JB, Fouad-Tarazi F. Plasma volume and outcome in pulmonary hypertension. Tex Heart Inst J. 2003; 30(4): 305–307.
Romanovsky A, Bagshaw S, Rosner MH. Hyponatremia and congestive heart failure: A marker of increased mortality and a target for therapy. International Journal of Nephrology. 2011; 2011: 732746. DOI: https://doi.org/10.4061/2011/732746
Forfia PR, Mathai SC, Fisher MR, Housten-Harris T, Hemnes AR, Champion HC, et al. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008; 177(12): 1364–1369. DOI: https://doi.org/10.1164/rccm.200712-1876OC
Vazir A, Cowie MR. Decongestion: Diuretics and other therapies for hospitalized heart failure. Indian Heart J. 2016; 68 Suppl 1: S61–S68. DOI: https://doi.org/10.1016/j.ihj.2015.10.386
Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010; 122(3): 265–272. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.933275
Parissis JT, Farmakis D, Nieminen M. Classical inotropes and new cardiac enhancers. Heart Fail Rev. 2007; 12(2): 149–156. DOI: https://doi.org/10.1007/s10741-007-9014-5
Kementerian Kesehatan Republik Indonesia. Keputusan menteri kesehatan Republik Indonesia nomor HK.01.07/MENKES/813/2019 tentang formularium nasional. 2019; 106–107.
Cao JY, Lee SY, Phan K, Celermajer DS, Lal S. Renin-angiotensin-aldosterone inhibition improves right ventricular function: a meta-analysis. Heart Asia. 2018; 10(1): e010999. DOI: https://doi.org/10.1136/heartasia-2018-010999
Handoko ML, de Man FS, Allaart CP, Paulus WJ, Westerhof N, Vonk-Noordegraaf A. Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: Lessons from the left heart. Eur Respir Rev. 2010; 19(115): 72–82. DOI: https://doi.org/10.1183/09059180.00007109
Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, et al. Evaluation and management of right-sided heart failure: A scientific statement from the American Heart Association. Circulation. 2018; 137(20): e578–e622. DOI: https://doi.org/10.1161/CIR.0000000000000560
Agbor VN, Ntusi NAB, Noubiap JJ. An overview of heart failure in low- and middle-income countries. Cardiovasc Diagn Ther. 2020; 10(2): 244–251. DOI: https://doi.org/10.21037/cdt.2019.08.03
留言 (0)